Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Enrollment completed in phase IIb study of valopicitabine for hepatitis C

June 2, 2005

Priority review for Remicade for ulcerative colitis

June 1, 2005

Favorable results for GW-6604 from preclinical models of liver fibrosis

June 1, 2005

Recent Kosan patents cover therapeutic agents for gastric motility disorders

May 31, 2005

Flavonoid derivative suppresses NF-kappaB activation in human colonic epithelial cells

May 31, 2005

Role of interleukin-13 in the pathogenesis of eosinophilic esophagitis

May 31, 2005

Santarus submits Zegerid chewable tablets NDA

May 31, 2005

Blocking cathepsins alleviates experimental colitis / News in Context

May 30, 2005

Novel therapeutic agents for gastrointestinal disorders revealed in patents

May 27, 2005

Par and Optimer enter development and collaboration agreement for PAR-101

May 27, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...